Literature DB >> 7667105

STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.

P Lamb1, H M Seidel, J Haslam, L Milocco, L V Kessler, R B Stein, J Rosen.   

Abstract

Activation of members of the STAT (signal transducers and activators of transcription) family of latent transcription factors is an early event following the binding of many cytokines to their cognate receptors. Although the patterns of STATs activated by different cytokines are well described, the consequences of differential STAT activation are less well studied. We show by mutational analysis that STAT binding elements (SBEs) exist that discriminate between STAT complexes containing STAT1 alpha, STAT3 or both, and that these elements show altered cytokine responsiveness. We also show that in the context of a minimal promoter, single and multiple SBEs exhibit strikingly different patterns of transcriptional activation in response to IFN-gamma, IL-6, OSM or LIF. These differences in transcriptional activation are correlated with the differential ability of these cytokines to activate STAT1 alpha, STAT3 or both. Our results show that the pattern of STATs activated by a cytokine and the arrangement and sequence of the SBEs in the responding promoter have a profound effect on the ability of the cytokine to elicit a transcriptional response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667105      PMCID: PMC307189          DOI: 10.1093/nar/23.16.3283

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

Review 1.  Interleukin-6 and its receptor: a paradigm for cytokines.

Authors:  T Kishimoto; S Akira; T Taga
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

Review 2.  Jaks and Stats in signaling by the cytokine receptor superfamily.

Authors:  J N Ihle; I M Kerr
Journal:  Trends Genet       Date:  1995-02       Impact factor: 11.639

3.  A common nuclear signal transduction pathway activated by growth factor and cytokine receptors.

Authors:  H B Sadowski; K Shuai; J E Darnell; M Z Gilman
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

4.  Induction of the Ly-6A/E gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds.

Authors:  K D Khan; K Shuai; G Lindwall; S E Maher; J E Darnell; A L Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

5.  Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3.

Authors:  R N Pearse; R Feinman; K Shuai; J E Darnell; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds.

Authors:  Y Kanno; C A Kozak; C Schindler; P H Driggers; D L Ennist; S L Gleason; J E Darnell; K Ozato
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma.

Authors:  K Shuai; G R Stark; I M Kerr; J E Darnell
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

8.  Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation.

Authors:  O Silvennoinen; C Schindler; J Schlessinger; D E Levy
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

9.  Tyrosine phosphorylation of DNA binding proteins by multiple cytokines.

Authors:  A C Larner; M David; G M Feldman; K Igarashi; R H Hackett; D S Webb; S M Sweitzer; E F Petricoin; D S Finbloom
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

10.  Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level.

Authors:  U M Wegenka; J Buschmann; C Lütticken; P C Heinrich; F Horn
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

View more
  15 in total

1.  Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.

Authors:  Kathryn L Pothoven; James E Norton; Kathryn E Hulse; Lydia A Suh; Roderick G Carter; Erin Rocci; Kathleen E Harris; Stephanie Shintani-Smith; David B Conley; Rakesh K Chandra; Mark C Liu; Atsushi Kato; Nirmala Gonsalves; Leslie C Grammer; Anju T Peters; Robert C Kern; Paul J Bryce; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2015-04-01       Impact factor: 10.793

Review 2.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

3.  Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier (Imiquimod) in genital warts.

Authors:  I Arany; S K Tyring; M M Brysk; M A Stanley; M A Tomai; R L Miller; M H Smith; D J McDermott; H B Slade
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

4.  Mimicry of erythropoietin by a nonpeptide molecule.

Authors:  S A Qureshi; R M Kim; Z Konteatis; D E Biazzo; H Motamedi; R Rodrigues; J A Boice; J R Calaycay; M A Bednarek; P Griffin; Y D Gao; K Chapman; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

5.  An alternative splice product of IkappaB kinase (IKKgamma), IKKgamma-delta, differentially mediates cytokine and human T-cell leukemia virus type 1 tax-induced NF-kappaB activation.

Authors:  Tao Hai; Man-Lung Yeung; Thomas G Wood; Yuanfen Wei; Shoji Yamaoka; Zoran Gatalica; Kuan-Teh Jeang; Allan R Brasier
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.

Authors:  R Moriggl; V Gouilleux-Gruart; R Jähne; S Berchtold; C Gartmann; X Liu; L Hennighausen; A Sotiropoulos; B Groner; F Gouilleux
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat.

Authors:  W Qin; T V Golovkina; T Peng; I Nepomnaschy; V Buggiano; I Piazzon; S R Ross
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.

Authors:  F Verdier; R Rabionet; F Gouilleux; C Beisenherz-Huss; P Varlet; O Muller; P Mayeux; C Lacombe; S Gisselbrecht; S Chretien
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  Murine gammaherpesvirus 68 has evolved gamma interferon and stat1-repressible promoters for the lytic switch gene 50.

Authors:  Megan M Goodwin; Susan Canny; Ashley Steed; Herbert W Virgin
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.

Authors:  Inès Souissi; Patrick Ladam; Jean A H Cognet; Stéphanie Le Coquil; Nadine Varin-Blank; Fanny Baran-Marszak; Valeri Metelev; Remi Fagard
Journal:  Mol Cancer       Date:  2012-03-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.